MEK inhibition and phosphorylation of serine 4 on B23 are two coincident events in mitosis

Biochem Biophys Res Commun. 2004 Aug 27;321(3):675-80. doi: 10.1016/j.bbrc.2004.07.024.

Abstract

Previous studies have shown that activation of the Raf/MEK/ERK pathway is necessary for G2/M transition. However, as for the activation state of MEK in mitosis the conclusion is not consistent. Here we show that MEK is inhibited in mitosis. In addition, we identify a multifunctional protein named B23 that strongly cross-reacts with a phospho-MEK antibody in mitotic cells. Sequence homology between the N-terminus surrounding Ser 4 of B23 and the Raf phosphorylation site on MEK suggests a mechanism for cross-reaction of the antibody. Thus, mutation of Ser 4 to alanine abolishes cross-reactivity between B23 and the phospho-MEK antibody. Our findings may explain the discrepancy of results obtained with the use of phospho-MEK antibody regarding the activation state of MEK in mitosis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies / immunology
  • Antibodies, Phospho-Specific / metabolism
  • COS Cells
  • Chlorocebus aethiops
  • Cross Reactions
  • Enzyme Activation
  • Humans
  • MAP Kinase Signaling System / physiology
  • Membrane Proteins / metabolism*
  • Mice
  • Mitogen-Activated Protein Kinase Kinases / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinase Kinases / genetics
  • Mitogen-Activated Protein Kinase Kinases / immunology
  • Mitogen-Activated Protein Kinase Kinases / metabolism*
  • Mitosis*
  • NIH 3T3 Cells
  • Nuclear Proteins / immunology
  • Nuclear Proteins / metabolism*
  • Nucleophosmin
  • Phosphorylation
  • Serine / metabolism*

Substances

  • Antibodies
  • Antibodies, Phospho-Specific
  • Membrane Proteins
  • Npm1 protein, mouse
  • Nuclear Proteins
  • Nucleophosmin
  • Serine
  • Mitogen-Activated Protein Kinase Kinases